Schall Law Firm Invites PEPG Investors to Participate in Class Action Against PepGen Inc.

Class Action Lawsuit: PepGen Inc. Investors Invited to Join

The Schall Law Firm, a well-known national litigation firm dedicated to shareholder rights, has recently opened the door for investors affected by the misrepresentation of facts by PepGen Inc. (NASDAQ: PEPG) to participate in a class action lawsuit. This lawsuit addresses significant violations of the Securities Exchange Act of 1934, specifically citing sections 10(b) and 20(a) along with SEC Rule 10b-5.

The timeline for eligible investors spans from March 7, 2024, to March 3, 2025, a critical period where investors may have purchased securities of PepGen Inc. based on unreliable statements made by the company. Investors are urged to reach out to The Schall Law Firm before the deadline of August 8, 2025, to discuss their rights and consider joining this class action posthaste.

Misleading Statements and Allegations
According to the lawsuit, PepGen Inc. is accused of disseminating false and misleading information regarding its drug candidate PGN-EDO51. The allegations specify that the candidate was less effective and posed greater safety risks than what was publicly claimed, leading to significant investor losses when the truth emerged. Furthermore, the complaint highlights deficiencies in the CONNECT2 clinical study, suggesting it lacked necessary standards for FDA approval and posed dangers to the study's participants. The implications of these false statements caused considerable damage to shareholders when the real circumstances came to light.

Taking Necessary Action
For those who invested in PepGen Inc. during the aforementioned period and suffered financial losses, joining this class action presents an opportunity to reclaim losses due to the company's misconduct. The Schall Law Firm specializes in handling securities class action lawsuits and provides a free consultation to shareholders, allowing them to discuss their experiences and potential legal recourse.

Brian Schall, representative of the Schall Law Firm, encourages affected investors to connect either via telephone at 310-301-3335 or through their website at www.schallfirm.com. Potential claimants should be aware that the class in this case is not yet certified, meaning that until such a certification occurs, investors are not currently represented in court. Those opting not to take action will remain classified as absent class members, potentially forfeiting their rights to recover losses.

Conclusion
PepGen Inc.'s situation is a salient reminder of the responsibilities held by companies to uphold transparency and honesty with their shareholders. The Schall Law Firm continues to advocate for investor rights by highlighting the importance of appropriate legal action in the face of deceptive practices. As the class action progresses, impacted investors should consider their options carefully and take the crucial steps needed to protect their investments and financial interests in the ongoing legal landscape surrounding PepGen Inc.